PAM
EPZM

Panagora Asset Management’s Epizyme, Inc EPZM Stock Holding History

Panagora Asset Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-174
Closed -$2K – 3004
2020
Q4 		$2K Sell
174
-305,588
-100% -$3.77M ﹤0.01% 2674
2020
Q3 		$3.65M Buy
305,762
+57,810
+23% +$774K 0.02% 474
2020
Q2 		$3.98M Buy
247,952
+195,585
+373% +$3.41M 0.03% 459
2020
Q1 		$812K Buy
+52,367
New +$1.12M 0.01% 924
2016
Q1 		– Sell
-3,573
Closed -$57K – 2361
2015
Q4 		$57K Buy
3,573
+1,569
+78% +$23.3K ﹤0.01% 1942
2015
Q3 		$26K Buy
2,004
+414
+26% +$8.36K ﹤0.01% 2103
2015
Q2 		$38K Buy
+1,590
New +$30.6K ﹤0.01% 2201
2013
Q4 		– Sell
-35,338
Closed -$1.42M – 2273
2013
Q3 		$1.42M Buy
+35,338
New +$1.2M 0.01% 960

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Panagora Asset Management's EPZM Position: Q1 2021 in Review

Panagora Asset Management sold out of Epizyme, Inc (EPZM) in Q1 2021, closing a stake of 174 shares — an estimated $2K sold.

Panagora Asset Management first reported a position in EPZM in Q3 2013 and held it in 8 quarters. The position peaked at $3.98M in Q2 2020. 137 funds tracked by Wall St. Rank hold EPZM as of Q1 2021.

  • Panagora Asset Management reported no remaining Epizyme, Inc position as of Q1 2021 after selling out during the quarter.
  • Panagora Asset Management sold 174 Epizyme, Inc shares in Q1 2021, an estimated $2K.
  • Panagora Asset Management first reported a position in Epizyme, Inc in Q3 2013 and held it in 8 quarters.
  • Panagora Asset Management's Epizyme, Inc position peaked at $3.98M in Q2 2020.
  • 137 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2021.

Based on Panagora Asset Management's 13F filing for Q1 2021, filed 12 May 2021.